Theresa Marie Heggie — Head of Europe & Canada and Senior Vice President at Alnylam Pharmaceuticals

Ms. Theresa Marie Heggie has been the Head of Europe & Canada and Senior Vice President at Alnylam Pharmaceuticals, Inc. since May 09, 2017. Ms. Heggie served as the Chief Marketing and Strategy Officer at The British United Provident Association Limited from June 2013 to December 2015. She served as the Chief Executive Officer of Jerini AG. She served as Vice President and General Manager of Europe of Shire Human Genetic Therapies, Inc. (Shire HGT). She served as Vice President of Shire plc. She served as an European General Manager of Transkaryotic Therapies Inc. (TKT Europe) since March 2005. She served as the Chief Executive Officer and Member of Management Board of Shire Orphan Therapies GmbH since October 2008. She served as Vice President of Global Marketing for the Anesthesia and Critical Care Business of Baxter Healthcare. She has several years' of experience from a number of positions with a global responsibility within, among other things, sales and marketing of pharmaceuticals. Early in her career, she held Sales Representative positions at Dow Chemical and Janssen Pharmaceutical before assuming a variety of marketing positions at Ohmeda Pharmaceutical Products Division (PPD) from 1991 to 1998. She serves as a Director of HealthXL Limited. She served as a Director of Swedish Orphan Biovitrum AB from May 24, 2016 to April 7, 2017. She received a BSc from Cornell University.